Información sobre riesgo, prevención, detección, síntomas, diagnosis, tratamiento y apoyo para el cáncer.
Información sobre el tratamiento del cáncer incluyendo quirúrgica, quimioterapia, radioterapia, estudios clínicos, terapia con protón, medicina complementaria avanzadas.
OncoLink se complace en ofrecer una amplia lista de lista completa de los agentes quimioterapéuticos más comúnmente usados??. Esta guía de referencia incluye información sobre la forma en que cada fármaco se administra, cómo funcionan, y los pacientes los efectos secundarios comunes pueden experimentar.
Maneras que los pacientes de cáncer y las personas que le cuidan puedan enfrentar el cáncer, los efectos secundarios, nutrición, cuestiones en general sobre el apoyo para el cáncer, duelo/decisiones sobre el termino de vida, y experiencias compartidas por sobrevivientes.
Tipos de Cancer / Cánceres de la Piel / Sarcoma de Kaposi / Recursos de NCI
|
NCI CANCERLIT® Search: AIDS-Related Kaposi's Sarcoma - October 2001
AIDS-related cancers in the era of highly active antiretroviral therapy. The changing incidence of four AIDS-related malignancies in a large urban center. Effect of highly active antiretroviral therapy on survival in patients with... |
|
|
NCI CANCERLIT® Search: AIDS-Related Kaposi|s Sarcoma - September 2001
OncoLink: NCI CancerLit Search: AIDS-Related Kaposi's Sarcoma - September 2001 AIDS-Related Kaposi's Sarcoma - September 2001 Table of Contents [Kaposi's sarcoma another new infectious disease?] HHV-8 infection in patients with... |
|
|
NCI CANCERLIT® Search: AIDS-Related Kaposi's Sarcoma - April 2002
Prevalence of Kaposi sarcoma-associated herpesvirus infection in homosexual men at beginning of and during the HIV epidemic. Relationship between Kaposi sarcoma-associated herpesvirus and HIV. Relationship between Kaposi sarcoma-associated... |
|
|
NCI CANCERLIT® Search: AIDS-Related Kaposi's Sarcoma - August 2002
Management of AIDS-related Kaposi's sarcoma: advances in target discovery and treatment. Clinical trials referral resource. Clinical trials and NCI resources for cancer in HIV-positive patients. Human herpesvirus 8 cytoviraemia rebound... |
|
|
NCI CANCERLIT® Search: AIDS-Related Kaposi's Sarcoma - February 2002
Human immunodeficiency virus (HIV) infection codes and new codes for Kaposi's sarcoma. Prevalence of Kaposi sarcoma-associated herpesvirus infection in homosexual men at beginning of and during the HIV epidemic. Factors predictive of... |
|
|
NCI CANCERLIT® Search: AIDS-Related Kaposi's Sarcoma - January 2002
In vivo evaluation of 111In-DTPA-N-TIMP-2 in Kaposi sarcoma associated with HIV infection. Higher prevalence of antibodies to human herpesvirus 8 in HIV-infected individuals than in the general population in Ghana, West Africa. Response to... |
|
|
NCI CANCERLIT® Search: AIDS-Related Kaposi's Sarcoma - July 2002
Kaposi's sarcoma and protection from AIDS dementia complex. Kaposi's sarcoma and central nervous system disease: a real association or an artifact of the control group? Terry Beirn Community Programs for Response to Eberly et al., Kaposi's... |
|
|
NCI CANCERLIT® Search: AIDS-Related Kaposi's Sarcoma - June 2002
Actinomycin D-mediated sensitization of AIDS-Kaposi's sarcoma cells to Fas-mediated apoptosis: involvement of the mitochondrion-dependent Table of Contents 1 UI - 11894131 AU - Mori S; Murakami-Mori K; Nakamura S; Bonavida B TI... |
|
|
NCI CANCERLIT® Search: AIDS-Related Kaposi's Sarcoma - March 2002
Complete remission of AIDS/Kaposi's sarcoma after treatment with a combination of two nucleoside reverse transcriptase inhibitors and one Kaposi's sarcoma-like lesions and other nodules as cutaneous involvement in AIDS-related visceral... |
|
|
NCI CANCERLIT® Search: AIDS-Related Kaposi's Sarcoma - May 2002
Virologic and immunologic parameters that predict clinical response of AIDS-associated Kaposi's sarcoma to highly active antiretroviral Minimum standard of care defined for HIV patients with cancer. Antitumor activity of oral 9-cis-retinoic... |
|
|
NCI CANCERLIT® Search: AIDS-Related Kaposi's Sarcoma - October 2002
Clinical manifestations of classical, endemic African, and epidemic AIDS-associated Kaposi's sarcoma. Recent developments in sexually transmitted diseases: is Kaposi's sarcoma a sexually transmitted disease? The epidemiology of classic,... |
|
|
NCI CANCERLIT® Search: AIDS-Related Kaposi's Sarcoma - September 2002
Phase II evaluation of low-dose oral etoposide for the treatment of relapsed or progressive AIDS-related Kaposi's sarcoma: an AIDS Clinical Development of Kaposi's sarcoma at the site of a biopsy. Development of Kaposi's sarcoma in a surgical... |
|
|
NCI/PDQ® Health professionals: Kaposi Sarcoma Treatment (PDQ®)
TABLE OF CONTENTS General Information About Kaposi SarcomaClassic Kaposi SarcomaAfrican Kaposi SarcomaImmunosuppressive TreatmentRelated Kaposi SarcomaEpidemic Kaposi SarcomaNonepidemic GayRelated Kaposi SarcomaStage Information for Kaposi... |
|
|
NCI/PDQ® Pacientes: Sarcoma de Kaposi
TABLE OF CONTENTS Descripción¿Qué es el sarcoma de Kaposi?Explicación de los estadiosEstadios del sarcoma de KaposiClásicoRelacionado con el tratamiento inmunodepresorEpidémicoRecurrenteAspectos generales de las... |
|
|
NCI/PDQ® Patients: Kaposi's Sarcoma
TABLE OF CONTENTS DescriptionWhat is Kaposi's sarcoma?Stage ExplanationStages of Kaposi's sarcomaClassicImmunosuppressive treatment relatedEpidemicRecurrentTreatment Option OverviewHow Kaposi's sarcoma is treatedTreatment by StageClassic Kaposi's... |
|
|
NCI/PDQ® Patients: Skin Cancer Prevention (PDQ®)
TABLE OF CONTENTS What is prevention?General Information About Skin CancerSkin Cancer PreventionChanges to This Summary (05/24/2012)Questions or Comments About This SummaryGet More Information From NCIAbout PDQ® What is prevention? Back UpCancer... |
|
|
NCI/PDQ® Profesionales De Salud: Sarcoma de Kaposi: Tratamiento (PDQ®)
TABLE OF CONTENTS Información general sobre el sarcoma de KaposiSarcoma de Kaposi clásicoSarcoma de Kaposi africanoSarcoma de Kaposi relacionado con el tratamiento inmunodepresor Sarcoma de Kaposi epidémicoSarcoma de Kaposi no... |
Dr. Vapiwala discusses the public awareness of prostate cancer and the public support for the disease. Read more.
Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet
Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy
Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies
Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer
Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults
OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews
Ask the Experts
Brown Bag Chat
Tracy's Corner
About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Cladribine (2-CDA, Leustatin®)
Cyclophosphamide (Cytoxan®, Neosar®, Endoxan®)
Cyclosporine (Neoral®, Sandimmune®, Restasis®, Gengraf®)
Cytarabine (Cytosar-U®, Ara-C)
Irinotecan (Camptosar®, CPT-11)
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Calcium Leucovorin, Citrovorum Factor, Folinic Acid
Leucovorin (Calcium Leucovorin, Citrovorum Factor, Folinic Acid)
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Men
Leuprolide Acetate (Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®) - For Women
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Lupron®, Lupron Depot®, Eligard®, Prostap®, Viadur®
Busulfan (Myleran®, Busulfex®)
Intravesicular Mitomycin (Mutamycin®, Mitomycin-C, given into the bladder)
Mechlorethamine (Mustargen®, Nitrogen Mustard)
mechlorethamine, mustine, Mustargen®
Megestrol (Megace®, Megace-ES®)
Mercaptopurine (Purinethol®, 6-MP)
Methotrexate (Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX)
Mexate®, Folex®, Rheumatrex®, Amethopterin, MTX
Mitomycin (Mutamycin®, Mitomycin-C)
Morphine Sulfate (Given by IV)
Morphine Sulfate (MS Contin®, Avinza®, Kadian®, Oramorph SR®)
MS Contin®, Avinza®, Kadian®, Oramorph SR®
Mutamycin®, Mitomycin-C, given into the bladder
Nitrogen mustard (mechlorethamine, mustine, Mustargen®)
Bendamustine Hydrochloride (Treanda®)
Bexarotene (Targretin®), Oral Formulation
Bexarotene Gel (Targretin® Gel Formulation)
Etoposide (Toposar®, VePesid®, Etopophos®,VP-16)
Thioguanine (6-TG, Thioguanine Tabloid®)
Toposar®, VePesid®, Etopophos®,VP-16
Trelstar LA® and Trelstar Depot®
Tretinoin (Vesanoid®, All-Trans-Retinoic Acid, ATRA)
Triptorelin (Trelstar LA® and Trelstar Depot®)

